Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.
Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
Trials. 2024 Feb 10;25(1):114. doi: 10.1186/s13063-024-07960-x.
Economic incentives can improve clinical outcomes among in-care people living with HIV (PLHIV), but evidence is limited for their effectiveness among out-of-care PLHIV or those at risk of disengagement. We propose a type 1 hybrid effectiveness-implementation study to advance global knowledge about the use of economic incentives to strengthen the continuity of HIV care and accelerate global goals for HIV epidemic control.
The Rudi Kundini, Pamoja Kundini study will evaluate two implementation models of an economic incentive strategy for supporting two groups of PLHIV in Tanzania. Phase 1 of the study consists of a two-arm, cluster randomized trial across 32 health facilities to assess the effectiveness of a home visit plus one-time economic incentive on the proportion of out-of-care PLHIV with viral load suppression (< 1000 copies/ml) 6 months after enrollment (n = 640). Phase 2 is an individual 1:1 randomized controlled trial designed to determine the effectiveness of a short-term counseling and economic incentive program offered to in-care PLHIV who are predicted through machine learning to be at risk of disengaging from care on the outcome of viral load suppression at 12 months (n = 692). The program includes up to three incentives conditional upon visit attendance coupled with adapted counselling sessions for this population of PLHIV. Consistent with a hybrid effectiveness-implementation study design, phase 3 is a mixed methods evaluation to explore barriers and facilitators to strategy implementation in phases 1 and 2. Results will be used to guide optimization and scale-up of the incentive strategies, if effective, to the larger population of Tanzanian PLHIV who struggle with continuity of HIV care.
Innovative strategies that recognize the dynamic process of lifelong retention in HIV care are urgently needed. Strategies such as conditional economic incentives are a simple and effective method for improving many health outcomes, including those on the HIV continuum. If coupled with other supportive services such as home visits (phase 1) or with tailored counselling (phase 2), economic incentives have the potential to strengthen engagement among the subpopulation of PLHIV who struggle with retention in care and could help to close the gap towards reaching global "95-95-95" goals for ending the AIDS epidemic.
Phase 1: ClinicalTrials.gov, NCT05248100 , registered 2/21/2022. Phase 2: ClinicalTrials.gov, NCT05373095 , registered 5/13/2022.
经济激励措施可以改善接受治疗的艾滋病毒感染者(PLHIV)的临床结局,但在脱离治疗的 PLHIV 或有脱离风险的人群中,其有效性证据有限。我们提出了一种 1 型混合有效性-实施研究,旨在增进全球对使用经济激励措施加强艾滋病毒护理连续性和加速全球艾滋病毒流行控制目标的认识。
Rudi Kundini、Pamoja Kundini 研究将评估在坦桑尼亚为两组 PLHIV 实施经济激励策略的两种实施模式。研究的第一阶段包括在 32 个卫生机构进行的两项、集群随机试验,以评估家访加一次性经济激励对 6 个月后病毒载量抑制(<1000 拷贝/ml)的脱离治疗 PLHIV 比例的影响(n=640)。第二阶段是个体 1:1 随机对照试验,旨在确定对通过机器学习预测有脱离治疗风险的接受治疗的 PLHIV 提供短期咨询和经济激励方案的有效性,该方案包括最多三次激励,取决于就诊情况,并为这一 PLHIV 人群提供适应的咨询会议。根据混合有效性-实施研究设计,第三阶段是一项混合方法评估,以探索第一和第二阶段策略实施的障碍和促进因素。如果有效,结果将用于指导激励策略在更大的坦桑尼亚 PLHIV 人群中的优化和扩大,这些人在艾滋病毒护理的连续性方面存在困难。
迫切需要创新策略,认识到终生保留在艾滋病毒护理中的动态过程。有条件的经济激励等策略是改善许多健康结果的简单而有效的方法,包括艾滋病毒连续体中的结果。如果与家访(第一阶段)或量身定制的咨询(第二阶段)等其他支持性服务相结合,经济激励有可能加强那些在保留护理方面存在困难的 PLHIV 亚人群的参与,有助于缩小差距,实现全球“95-95-95”目标,即终结艾滋病流行。
第一阶段:ClinicalTrials.gov,NCT05248100,2022 年 2 月 21 日注册。第二阶段:ClinicalTrials.gov,NCT05373095,2022 年 5 月 13 日注册。